141 related articles for article (PubMed ID: 9336381)
21. Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization.
Jafri F; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):713-7. PubMed ID: 16740986
[TBL] [Abstract][Full Text] [Related]
22. Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail.
Emoto N; Nurhantari Y; Alimsardjono H; Xie J; Yamada T; Yanagisawa M; Matsuo M
J Biol Chem; 1999 Jan; 274(3):1509-18. PubMed ID: 9880527
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a.
Kulathila R; Clark K; Savage P; Bowen BR; Emoto N; Yanagisawa M; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():94S-97S. PubMed ID: 12193063
[TBL] [Abstract][Full Text] [Related]
24. Novel selective quinazoline inhibitors of endothelin converting enzyme-1.
Ahn K; Sisneros AM; Herman SB; Pan SM; Hupe D; Lee C; Nikam S; Cheng XM; Doherty AM; Schroeder RL; Haleen SJ; Kaw S; Emoto N; Yanagisawa M
Biochem Biophys Res Commun; 1998 Feb; 243(1):184-90. PubMed ID: 9473502
[TBL] [Abstract][Full Text] [Related]
25. Identification of amino acid residues in the C-terminal tail of big endothelin-1 involved in processing to endothelin-1.
Brooks C; Ergul A
J Mol Endocrinol; 1998 Dec; 21(3):307-15. PubMed ID: 9845671
[TBL] [Abstract][Full Text] [Related]
26. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells.
Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S
Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091
[TBL] [Abstract][Full Text] [Related]
27. Functional evidence for the presence of a phosphoramidon-sensitive enzyme in rat brain that converts big endothelin-1 to endothelin-1.
Hashim MA; Tadepalli AS
Life Sci; 1991; 49(24):PL207-11. PubMed ID: 1943480
[TBL] [Abstract][Full Text] [Related]
28. Endothelin peptide and converting enzymes in human endothelium.
Russell FD; Skepper JN; Davenport AP
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S19-21. PubMed ID: 9595389
[TBL] [Abstract][Full Text] [Related]
29. New short peptide substrates of endothelin-converting enzyme and characterization of the enzyme.
Létourneau M; Roby P; Tremblay F; Carette J; Fournier A
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S28-9. PubMed ID: 11078327
[TBL] [Abstract][Full Text] [Related]
30. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-converting enzyme-1-mediated signaling in adult rat ventricular myocyte contractility and apoptosis during sepsis.
Gupta A; Aberle NS; Ren J; Sharma AC
J Mol Cell Cardiol; 2005 Mar; 38(3):527-37. PubMed ID: 15733912
[TBL] [Abstract][Full Text] [Related]
32. Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells.
Russell FD; Davenport AP
Circ Res; 1999 Apr; 84(8):891-6. PubMed ID: 10222335
[TBL] [Abstract][Full Text] [Related]
33. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.
Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574
[TBL] [Abstract][Full Text] [Related]
34. Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.
Deprez-Roy I; Coge F; Bertry L; Galizzi JP; Feletou M; Vanhoutte PM; Canet E
Acta Pharmacol Sin; 2000 Jun; 21(6):499-506. PubMed ID: 11360683
[TBL] [Abstract][Full Text] [Related]
35. Role of the hydrophobic transmembrane domain in membrane anchoring of endothelin-converting enzyme-1a.
Brooks SC; Ergul A
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S30-2. PubMed ID: 11078328
[TBL] [Abstract][Full Text] [Related]
36. Cloning and functional expression of human endothelin-converting enzyme cDNA.
Shimada K; Matsushita Y; Wakabayashi K; Takahashi M; Matsubara A; Iijima Y; Tanzawa K
Biochem Biophys Res Commun; 1995 Feb; 207(2):807-12. PubMed ID: 7864876
[TBL] [Abstract][Full Text] [Related]
37. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.
Patel KV; Schrey MP
Br J Cancer; 1995 Mar; 71(3):442-7. PubMed ID: 7880721
[TBL] [Abstract][Full Text] [Related]
38. Localization of endothelin-converting enzyme in bovine optic nerve and retina.
Dibas A; Prasanna G; Yorio T
J Ocul Pharmacol Ther; 2005 Aug; 21(4):288-97. PubMed ID: 16117692
[TBL] [Abstract][Full Text] [Related]
39. Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1.
Tchekneva E; Lawrence ML; Meyrick B
Am J Physiol Lung Cell Mol Physiol; 2000 Apr; 278(4):L813-21. PubMed ID: 10749759
[TBL] [Abstract][Full Text] [Related]
40. A simple method for measurement of phosphoramidon-sensitive endothelin converting enzyme activity.
Matsumura Y; Umekawa T; Kawamura H; Takaoka M; Robinson PS; Cook ND; Morimoto S
Life Sci; 1992; 51(20):1603-11. PubMed ID: 1435068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]